Novel oral pharmaceutical suspension of cefdinir crystal
AssigneeAstellas Pharma Inc.
InventorsNaozumi Ohnishi, Shuhei Deguchi, Satoshi Kitamura
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel oral pharmaceutical suspension of Cefdinir crystal. More specifically, the present invention relates to a novel kit for preparation of an oral pharmaceutical suspension containing crystal forrn C Cefdinir.
Claims14
A kit for preparation of an oral pharmaceutical suspension of crystal form C of Cefdinir, wherein said kit comprises:
- (a) a composition comprising Cefdinir within a first container;
- and
- (b) a label or a written material indicating that said composition is admixed with pharmaceutically acceptable aqueous carrier prior to administration,
- wherein said composition when admixed with said carrier forms an oral pharmaceutical suspension of crystal form C of Cefdinir.
A kit for preparation of an oral pharmaceutical suspension of crystal form C of Cefdinir, wherein said kit comprises:
- (a) a composition comprising a lower hydrate of Cefdinir within a first container;
- and
- (b) a label or a written material indicating that said composition is admixed with pharmaceutically acceptable aqueous carrier prior to administration,
- wherein said composition when admixed with said carrier forms an oral pharmaceutical suspension of crystal form C of Cefdinir.
An oral pharmaceutical suspension comprising crystal form C of Cefdinir, and a pharmaceutically acceptable aqueous carrier.
A method for preparing an oral pharmaceutical suspension comprising crystal form C of Cefdinir, comprising admixing composition containing the lower hydrate of Cefdinir with a pharmaceutically aqueous acceptable carrier.
A crystal form C of Cefdinir.
A pharmaceutical composition comprising crystal form C of Cefdinir.
Dependencies are inferred from the claim text.